India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.
from Times of India https://ift.tt/39ZeN7J
Find trending news, Grab latest news on trending and viral on social media, Breaking News, Latest News and Current News from FOXNews.com. Breaking news and video.
0 comments:
Post a Comment